Literature DB >> 3009010

Morphology and in vivo growth characteristics of an atypical murine proliferative osseous lesion induced in vitro.

J Schmidt, E Livne, V Erfle, W Gössner, M Silbermann.   

Abstract

Mandibular condyles of late embryonic NMRI mice were used to study the effect of the FBR murine osteosarcoma virus in an in vitro tissue culture system. Chondroprogenitor cells and chondroblastic cells present in the condylar tissue normally undergo rapid differentiation in vitro which results in an advanced stage of bone formation. The infection of condyles with FBR murine osteosarcoma virus induced the transformation of bone progenitor cells and the formation of an atypical proliferative osseous lesion. In markedly disorganized tissue many spindle-like cells, giant cells, and pleomorphic cells were seen together with the formation of large bone spicules and the heavy mineralization of osteoid-like material and of the remaining cartilage. Fibroblast-like cells were found to penetrate from the perichondrial zone into the condylar mass and also into the underlying collagen sponge. The in vivo growth characteristics of FBR murine osteosarcoma virus-infected condyles after 3 days in culture were studied via s.c. transplantation into syngeneic mice. Control condyles developed normal trabecular bone, whereas the infected condyles induced a strong cellular response with the presence of atypical cells and newly formed connective tissue and bone in situ. These observations raise the possibility of a novel approach for further investigations related to numerous aspects of virus-induced osteosarcomagenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009010

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Bone formation by osteoblast-like cells in a three-dimensional cell culture.

Authors:  M Casser-Bette; A B Murray; E I Closs; V Erfle; J Schmidt
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

2.  Effects of leukemogenic retroviruses on condylar cartilage in vitro: an ultrastructural study.

Authors:  E Livne; J Schmidt; E I Closs; M Silbermann; V Erfle
Journal:  Calcif Tissue Int       Date:  1989-01       Impact factor: 4.333

3.  Osteosarcomagenic doses of radium (224Ra) and infectious endogenous retroviruses enhance proliferation and osteogenic differentiation of skeletal tissue differentiating in vitro.

Authors:  J Schmidt; K Heermeier; U Linzner; A Luz; M Silbermann; E Livne; V Erfle
Journal:  Radiat Environ Biophys       Date:  1994       Impact factor: 1.925

4.  Biochemical characterization of a virus-induced osteosarcoma-like osseous lesion in vitro.

Authors:  J Schmidt; E I Closs; E Livne; V Erfle; M Silbermann
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

5.  Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.

Authors:  Virna D Leaner; Jeffrey F Chick; Howard Donninger; Ilona Linniola; Arnulfo Mendoza; Chand Khanna; Michael J Birrer
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

6.  c-fos expression precedes osteogenic differentiation of cartilage cells in vitro.

Authors:  E I Closs; A B Murray; J Schmidt; A Schön; V Erfle; P G Strauss
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

7.  Gene expression during osteogenic differentiation in mandibular condyles in vitro.

Authors:  P G Strauss; E I Closs; J Schmidt; V Erfle
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

8.  Osteoblasts are target cells for transformation in c-fos transgenic mice.

Authors:  A E Grigoriadis; K Schellander; Z Q Wang; E F Wagner
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

Review 9.  MicroRNAs and Potential Targets in Osteosarcoma: Review.

Authors:  Valerie B Sampson; Soonmoon Yoo; Asmita Kumar; Nancy S Vetter; E Anders Kolb
Journal:  Front Pediatr       Date:  2015-08-24       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.